Bluebird Mining Ventures (BMV), a gold development company, has executed a £2 million Investment Agreement with Skylake Management LLP, an investment vehicle domiciled in United Kingdom. £2 million by way of
RNS Hotlist with Zak Mir: AZN, HEMO, POW, FDR, GMET, BZT, GGP, PR1, EPP, JET2, FTC & BARC
The Times: FTSE 100 drugs giant AstraZeneca (AZN) has posted better-than-expected interim results boosted by strong sales of key cancer, heart and kidney disease drugs. Operating profit rose 23 per cent to $7.18
Hemogenyx Pharma Plc (LON:HEMO) Awarded G-Rex® Grant to Support Scalable, Cost-Optimized CAR-T Manufacturing
Hemogenyx Pharmaceuticals Awarded G-Rex® Grant to Support Scalable, Cost-Optimized CAR-T Manufacturing
RNS Hotlist with Zak Mir: SWC, STG, EEE, KEFI, HEMO, CRDL, ITX & EUA
BBC: Prices rose by more than expected to 3.6% in the year to June, the steepest rise in inflation since January 2024, the Office for National Statistics (ONS) said.That marks a
Hemogenyx Pharma Plc (LON:HEMO) Second Patient Passes Initial Safety Tests
Second Patient Treated with HG-CT-1 CAR-T Therapy Successfully Passes Initial Safety Evaluation
RNS Hotlist with Zak Mir: VLRM, PR1, AAU, DCTA, TCF, MKA, HEMO, HE1, RBW & SVNS
Valereum (AQSE: VLRM) announced a placing by Fortified Securities for a total of £0.5 million at an issue price of £0.04.
RNS Hotlist with Zak Mir: RBD, TXP, VLRM, ROAD, MSMN, KMK, MIRI, BEM, GEX, SFOR, FRP, AREC, SBDS, POLX, HEMO & NXT
Reabold Resources (RBD), the investing company focussed on developing strategic gas projects for European energy security, is pleased to announce that it has converted £500,000 of outstanding convertible loan notes into
Share Talk Weekly Stock Market News Review, Sunday 4th May 2025
The UK’s benchmark FTSE 100 index closed higher on Friday, extending its longest-ever streak of gains.
Hemogenyx Pharma Plc (LON:HEMO) Second Patient Treated with HG-CT-1 CAR-T Therapy
Hemogenyx Pharmaceuticals plc (LSE: HEMO) is pleased to announce that the second patient has been successfully treated as part of the Company’s ongoing Phase I clinical trial of HG-CT-1, its
RNS Hotlist with Zak Mir: AVCT, CUSN, ECOB, MDH, CYAN, THR, GRX, PLSR, EEE, EST, HEMO & EMH
Avacta Therapeutics (AVCT), a life sciences company developing next generation peptide drug conjugates (PDC) targeting powerful anti-tumor payloads directly to the tumor, announced preclinical results from its second pre|CISION® candidate FAP-EXd
Share Talk Weekly Stock Market News Review, Sunday 6th April 2025
Global stock markets have shed $4.9 trillion (£3.8 trillion) in value since Donald Trump’s “liberation day” speech on Wednesday, according to an analysis by a stockbroker.
RNS Hotlist with Zak Mir: HEMO, GEMR, CURY, ORCP, MET1, JLP, AAU, MOTR, SWT & MOON
Hemogenyx Pharmaceuticals (HEMO) announced that it has submitted its Annual Report to the FDA under the active Investigational New Drug (IND) application for HG-CT-1, the Company’s proprietary CAR-T cell therapy for